Hanna PE[au] - Search Results

Year	Number of Results
1970	2
1972	1
1973	2
1974	2
1976	1
1977	1
1978	1
1979	1
1980	2
1981	2
1982	5
1983	1
1984	2
1985	2
1986	1
1988	2
1989	1
1990	4
1991	1
1992	3
1993	2
1994	3
1995	3
1996	1
1997	2
1998	2
2003	2
2004	4
2005	4
2006	2
2007	4
2008	2
2009	2
2015	1
2019	1
2022	0

1

The mercapturic acid pathway.

Hanna PE, Anders MW. Hanna PE, et al. Crit Rev Toxicol. 2019 Nov;49(10):819-929. doi: 10.1080/10408444.2019.1692191. Epub 2020 Jan 16. Crit Rev Toxicol. 2019. PMID: 31944156

2

Arylamine N-acetyltransferase I.

Minchin RF, Hanna PE, Dupret JM, Wagner CR, Rodrigues-Lima F, Butcher NJ. Minchin RF, et al. Among authors: hanna pe. Int J Biochem Cell Biol. 2007;39(11):1999-2005. doi: 10.1016/j.biocel.2006.12.006. Epub 2007 Jan 20. Int J Biochem Cell Biol. 2007. PMID: 17392017

3

N-acetyltransferases, O-acetyltransferases, and N,O-acetyltransferases: enzymology and bioactivation.

Hanna PE. Hanna PE. Adv Pharmacol. 1994;27:401-30. doi: 10.1016/s1054-3589(08)61041-8. Adv Pharmacol. 1994. PMID: 8068562 Review. No abstract available.

4

Arylamine N-acetyltransferase aggregation and constitutive ubiquitylation.

Liu F, Zhang N, Zhou X, Hanna PE, Wagner CR, Koepp DM, Walters KJ. Liu F, et al. Among authors: hanna pe. J Mol Biol. 2006 Aug 18;361(3):482-92. doi: 10.1016/j.jmb.2006.06.029. Epub 2006 Jun 30. J Mol Biol. 2006. PMID: 16857211

5

Catalytic mechanism of hamster arylamine N-acetyltransferase 2.

Wang H, Liu L, Hanna PE, Wagner CR. Wang H, et al. Among authors: hanna pe. Biochemistry. 2005 Aug 23;44(33):11295-306. doi: 10.1021/bi047564q. Biochemistry. 2005. PMID: 16101314

6

Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.

Kawamura A, Graham J, Mushtaq A, Tsiftsoglou SA, Vath GM, Hanna PE, Wagner CR, Sim E. Kawamura A, et al. Among authors: hanna pe. Biochem Pharmacol. 2005 Jan 15;69(2):347-59. doi: 10.1016/j.bcp.2004.09.014. Epub 2004 Nov 24. Biochem Pharmacol. 2005. PMID: 15627487

7

Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.

Liu L, Wagner CR, Hanna PE. Liu L, et al. Among authors: hanna pe. Chem Res Toxicol. 2009 Dec;22(12):1962-74. doi: 10.1021/tx9002676. Chem Res Toxicol. 2009. PMID: 19842618

8

Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenes.

Marhevka VC, Ebner NA, Sehon RD, Hanna PE. Marhevka VC, et al. Among authors: hanna pe. J Med Chem. 1985 Jan;28(1):18-24. doi: 10.1021/jm00379a005. J Med Chem. 1985. PMID: 3965709

9

Calpain inhibition but not reticulum endoplasmic stress preconditioning protects rat kidneys from p-aminophenol toxicity.

Peyrou M, Hanna PE, Cribb AE. Peyrou M, et al. Among authors: hanna pe. Toxicol Sci. 2007 Sep;99(1):338-45. doi: 10.1093/toxsci/kfm105. Epub 2007 Jun 12. Toxicol Sci. 2007. PMID: 17567592

10

Over-expression, purification, and characterization of recombinant human arylamine N-acetyltransferase 1.

Wang H, Vath GM, Kawamura A, Bates CA, Sim E, Hanna PE, Wagner CR. Wang H, et al. Among authors: hanna pe. Protein J. 2005 Feb;24(2):65-77. doi: 10.1007/s10930-004-1513-9. Protein J. 2005. PMID: 16003948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results